eMurmur ID vs Imbio PHA (4.0.0)
AI Verdict
Choose eMurmur ID if…
Choose eMurmur ID if you require an AI-powered mobile and cloud solution for real-time heart murmur detection and classification using an electronic stethoscope. This tool is ideal for clinicians needing immediate decision support for initial screenings, telehealth consultations, and identifying pathologic or innocent murmurs at the point of care.
View eMurmur ID →Choose Imbio PHA (4.0.0) if…
Choose Imbio PHA if your practice involves analyzing CT pulmonary angiogram (CTPA) scans and you need automated, AI-powered measurements of cardiac structures. This software is best suited for radiologists and cardiologists seeking to assess right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension.
View Imbio PHA (4.0.0) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | eMurmur ID | Imbio PHA (4.0.0) |
|---|---|---|
| Deployment | Cloud, Mobile, API integration | Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
eMurmur IDeMurmur ID offers a mobile app with real-time feedback for heart sound analysis, making it highly interactive and accessible for clinicians at the point of care. This direct, mobile-first approach likely provides a more immediate and intuitive user experience compared to Imbio PHA's integration into existing, more complex radiology workflows.
Clinical Value
Imbio PHA (4.0.0)Imbio PHA provides automated, quantitative measurements from CTPA scans for critical conditions like pulmonary embolism and hypertension, directly aiding in diagnosis, risk stratification, and treatment decisions with objective data. While eMurmur ID offers valuable decision support for heart murmur detection, Imbio PHA's impact on high-stakes patient management is arguably more immediate and measurable.
Pricing & Value
TieBoth eMurmur ID and Imbio PHA require potential customers to contact the vendor directly for pricing information. Without transparent pricing models or detailed cost-benefit analyses provided, it is impossible to determine which tool offers superior value.
Enterprise Readiness
TieBoth tools demonstrate strong enterprise readiness, being FDA-cleared, HIPAA compliant, and offering BAA. They both support flexible deployment options including cloud and on-premise. Imbio PHA highlights third-party HIPAA certification, while eMurmur ID explicitly mentions hybrid deployments and EHR integration, balancing their enterprise capabilities.
Innovation
eMurmur IDeMurmur ID innovates by applying AI to a traditional, often subjective, physical examination (auscultation) at the point of care, leveraging mobile technology and third-party stethoscopes for real-time feedback. This approach is highly disruptive in democratizing diagnostic skill and enhancing early screening. Imbio PHA's automation of complex image analysis is also innovative but builds on established imaging diagnostics.
Support & Docs
Imbio PHA (4.0.0)Imbio PHA offers a more comprehensive and clearly outlined support structure, including multiple contact methods like phone, email, and an online case submission form, along with specified support hours. They also explicitly state the availability of user manuals and support documents upon request. eMurmur ID primarily provides an email address for general support.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | eMurmur ID | Imbio PHA (4.0.0) |
|---|---|---|
| Tool Name | eMurmur ID | Imbio PHA (4.0.0) |
| Primary Function | AI-powered mobile and cloud solution for detecting and classifying heart murmurs using a third-party electronic stethoscope, providing decision support for healthcare providers. | FDA-cleared AI-powered medical image processing software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. |
| Company | CSD Labs GmbH | Imbio |
| Tagline | AI-powered & telehealth-enabled | Transforming Imaging with AI to turn medical images into life-changing insights. |
| Input Data Type & Analysis Focus | Heart sounds from 3rd party electronic stethoscopes; detects and classifies heart murmurs, S1, S2 heart sounds. | CT pulmonary angiogram (CTPA) scans; measures cardiac structures (RV, LV, PA, Aorta diameters) and calculates ratios (RV/LV, PA/Ao). |
Videos
Demos, reviews, and walkthroughs featuring eMurmur ID and Imbio PHA (4.0.0).